Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach

International Journal of Public Health

Volumn 60, Issue 1, 2014, Pages 13-21

  Sözmen, Kaan ^a   Unal, Belgin ^b   Capewell, Simon ^c   Critchley, Julia ^d   O’Flaherty, Martin ^c  

^a IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Diabetes; Intervention; Markov model; Obesity; Projection

Indexed keywords

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; OBESITY; PREVALENCE; PREVENTION AND CONTROL; PROBABILITY; RISK FACTOR; SMOKING; TURKEY;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SMOKING; TURKEY;

EID: 84925511572     PISSN: 16618556     EISSN: 1420911X     Source Type: Journal    
DOI: 10.1007/s00038-014-0622-2     Document Type: Article

References (41)

1. Abu-Rmeileh NM, Husseini A, Capewell S, O’Flaherty M (2013) Preventing type 2 diabetes among Palestinians: comparing five future policy scenarios. BMJ Open 3:e003558. doi:10.1136/bmjopen-2013-003558
2. Akgun S, Rao C, Yardim N, Basara BB, Aydin O, Mollahaliloglu S et al (2007) Estimating mortality and causes of death in Turkey: methods, results and policy implications. Eur J Public Health 17:593–599. doi:10.1093/eurpub/ckm022
3. Al Ali R, Mzayek F, Rastam S, Fouad MF, O’Flaherty M, Capewell S et al (2013) Forecasting future prevalence of type 2 diabetes mellitus in Syria. BMC Public Health 13:507. doi:10.1186/1471-2458-13-507
4. Al-Quwaidhi AJ, Pearce MS, Sobngwi E, Critchley JA, O’Flaherty M (2014) Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies. Diabetes Res Clin Pract. doi:10.1016/j.diabres.2013.12.036
5. Bagriacik NOH, Ilhan B, Tarakci T, Osar Z, Ozyazar M, Hatemi HH, Yildiz G (2009) Obesity profile in Turkey Int J. Diabetes Metab 17:5–8
6. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ (2003) A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr 1:4
7. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF (2010) Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 8:29 1478-7954-8-29
8. Briggs A, Sculpher M, Buxton M (1994) Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 3:95–104
9. Brownell KD, Farley T, Willett WC, Popkin BM, Chaloupka FJ, Thompson JW et al (2009) The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med 361:1599–1605. doi:10.1056/NEJMhpr0905723
10. Ergor G, Soysal A, Sozmen K, Unal B, Ucku R, Kilic B et al (2012) Balcova heart study: rationale and methodology of the Turkish cohort. Int J Public Health 57:535–542. doi:10.1007/s00038-011-0309-x
11. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ et al (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377:557–567. doi:10.1016/S0140-6736(10)62037-5
12. Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:491–497. doi:10.1001/jama.2012.39
13. Hu FB (2011) Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34:1249–1257. doi:10.2337/dc11-0442
14. Kostova D, Andes L, Erguder T, Yurekli A, Keskinkilic B, Polat S et al (2014) Cigarette prices and smoking prevalence after a tobacco tax increase—Turkey, 2008 and 2012. Morb Mortal Wkly Rep 63:457–461
15. Loveman E, Frampton GK, Shepherd J, Picot J, Cooper K, Bryant J et al (2011) The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review. Health Technol Assess 15:1–182. doi:10.3310/hta15020
16. Luke A, Cooper RS (2013) Physical activity does not influence obesity risk: time to clarify the public health message. Int J Epidemiol 42:1831–1836. doi:10.1093/ije/dyt159
17. Magliano DJ, Barr EL, Zimmet PZ, Cameron AJ, Dunstan DW, Colagiuri S et al (2008) Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes. Obes Lifestyle Study Diabetes Care 31:267–272. doi:10.2337/dc07-0912
18. Maziak W, Critchley J, Zaman S, Unwin N, Capewell S, Bennett K et al (2013) Mediterranean studies of cardiovascular disease and hyperglycemia: analytical modeling of population socio-economic transitions (MedCHAMPS)-rationale and methods. Int J Public Health 58:547–553. doi:10.1007/s00038-012-0423-4
19. Mikus CR, Oberlin DJ, Libla JL, Taylor AM, Booth FW, Thyfault JP (2012) Lowering physical activity impairs glycemic control in healthy volunteers. Med Sci Sports Exerc 44:225–231. doi:10.1249/MSS.0b013e31822ac0c0
20. MoH (2010) Obesity prevention and control program of Turkey (2010-2014). Ministry of Health of Turkey, Ankara
21. MoH (2011) Türkiye Diyabeti Önleme ve Kontrol Programı. Eylem Planı 2011–2014. Sağlık Bakanlığı, Ankara
22. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study. Lancet 380:2197–2223. doi:10.1016/S0140-6736(12)61689-4
23. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ (2006) Impact of recent increase in incidence on future diabetes burden: US, 2005–2050. Diabetes Care 29:2114–2116. doi:10.2337/dc06-1136
24. Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S et al (2002) Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care 25:1551–1556
25. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N et al (2013) Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 28:169–180. doi:10.1007/s10654-013-9771-5
26. Schneider H, Dietrich ES, Venetz WP (2010) Trends and stabilization up to 2022 in overweight and obesity in Switzerland, comparison to France. UK, US and Aust Int J Environ Res Public Health 7:460–472. doi:10.3390/ijerph7020460
27. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14 S0168-8227(09)00432-X
28. Siegel M, Luengen M, Stock S (2013) On age-specific variations in income-related inequalities in diabetes, hypertension and obesity. Int J Public Health 58:33–41. doi:10.1007/s00038-012-0368-7
29. Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM et al (2012) National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr 10:22. doi:10.1186/1478-7954-10-22
30. Suleymanlar G, Utas C, Arinsoy T, Ates K, Altun B, Altiparmak MR et al (2011) A population-based survey of chronic renal disease in Turkey—the CREDIT study. Nephrol Dial Transplant 26:1862–1871. doi:10.1093/ndt/gfq656
31. Tatar M (2013) Management of diabetes and diabetes policies in Turkey. Global Health 9:16. doi:10.1186/1744-8603-9-16
32. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S, Group PI-W (2009) The prospective urban rural epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 158(1–7):e1. doi:10.1016/j.ahj.2009.04.019
33. TUIK (2013) Population census. http://tuikapp.tuik.gov.tr/nufusmenuapp/menu.zul. Accessed 14 Oct 2013
34. TURKSTAT (2013) Population projections. http://www.turkstat.gov.tr/PreHaberBultenleri.do?id=15844. Accessed 14 Oct 2013
35. Unal B, Sozmen K, Ucku R, Ergor G, Soysal A, Baydur H et al (2012) High prevalence of cardiovascular risk factors in a Western urban Turkish population: a community-based study. Anadolu Kardiyol Derg. doi:10.5152/akd.2013.002
36. Unwin N, Whiting D, Gan D (2009) Diabetes Atlas, 4th edn. International Diabetes Federation, Brussels
37. Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321 S0168-8227(11)00591-2
38. WHO (2011) Targets to monitor progress in reducing the burden of noncommunicable diseases, Recommendations from a WHO Technical Working Group on Noncommunicable Disease Targets World Health Organization. Accessed 14 Oct 2013
39. WHO (2013) Life expectancy: life tables Turkey. http://apps.who.int/gho/data/view.main.61710?lang=en. Accessed 14 Oct 2013
40. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
41. Yumuk VD (2005) Prevalence of obesity in Turkey. Obes Rev 6:9–10. doi:10.1111/j.1467-789X.2005.00172.x